Source: Bayer CropScience



Bayer CropScience is accelerating the extension of its biotech and seed business. Following a record year in 2008, the company is continuing its strategy of expansion, aiming systematically to expand its fast-growing business in seed and plant traits in the coming years. The intention is to more than triple sales in the BioScience segment to around EUR 1.4 billion by 2018, it was announced at the company's annual business report press conference.



"In this context, the company is planning to invest some EUR 3.5 billion in research and infrastructure for its biotech and seed business between now and 2018. This figure does not include possible acquisitions," said Friedrich Berschauer, Chairman of Bayer CropScience AG's Board of Management.



Original press release